International Partnerships Reshaped Pediatric Type 1 Diabetes Care Across 19 LMICs
Care for type 1 diabetes in children and adolescents has become more organized in many low- and middle-income countries, but the review makes plain how uneven that progress remains. Across 40 studies from 19 countries, care models were built around a familiar clinical problem: insulin alone is not enough when families cannot reliably obtain glucose testing, education, specialist follow-up, or support during acute metabolic crises. The review captures a field that has moved beyond isolated bedside treatment toward broader service design, with clinics, schools, camps, databases, and community programs all being used to close gaps in chronic disease care.
A single operational thread runs through nearly every model described here. Access to insulin, glucose monitoring supplies, and structured education was treated as the foundation of survival, not an optional add-on.
Multidisciplinary Clinics Became the Core Delivery Platform
Most models relied on multidisciplinary teams, and that structure mattered clinically because pediatric diabetes management requires repeated adjustment across growth, nutrition, physical activity, psychosocial development, and glycemic monitoring. In the African Region, models in Cameroon, Kenya, Rwanda, Tanzania, and Uganda were strongly linked to international initiatives such as Changing Diabetes in Children and Life for a Child. Those programs supported infrastructure and care delivery between 2004 and 2012, with efforts directed at insulin access, glucose monitoring supplies, and education for both children and caregivers.
Urban and rural delivery appeared in the same national programs, which is important because diabetes care gaps often widen once patients leave major cities. Some countries added tele-support and diabetes camps, extending education and clinical contact beyond formal appointments. Even so, financial and logistical barriers persisted despite government and humanitarian support. In practical terms, the review shows that a clinic team can be assembled, but continuity still falters when supplies, travel, and administrative systems remain fragile.
Free Insulin Did Not Eliminate Financial Friction
In several countries, insulin was available at no cost, yet out-of-pocket burdens continued to shape access to essential monitoring and follow-up. This pattern appeared repeatedly across regions and exposed a familiar blind spot in diabetes policy: removing the price of one medicine does not remove the cost of the rest of care.
The South-East Asia Region illustrates the point clearly. In Bangladesh, India, Myanmar, Sri Lanka, and Thailand, models implemented between 2009 and 2015 aimed to improve access to care, self-management education, and awareness among healthcare workers and communities, especially for children living below the poverty line. Supported by Changing Diabetes in Children, Life for a Child, and Action4Diabetes, these programs generally delivered outpatient care through multidisciplinary teams and provided free insulin and supplies in most countries. Regular HbA1c monitoring, diabetes education, and psychological support were repeatedly built into the model. Community awareness activities were also included in four countries. Still, financial barriers remained substantial, particularly in Bangladesh and Thailand, where the review identified persistent access problems despite programmatic support.
School Programs, Camps, and Family Education Extended Care Beyond the Clinic
Several countries moved care into spaces that traditionally sit outside endocrinology. Turkey’s National Childhood Diabetes Program included the Diabetes at School Program, a useful example of how diabetes management in children reaches into the classroom and depends on informed teachers and peers as much as on clinicians. Cuba’s model included holiday camps, while Morocco used group sessions, holiday camps, and tailored resources for illiterate parents. These are not peripheral features. For children with type 1 diabetes, repeated education in daily self-management can reduce errors in insulin use, improve recognition of hypoglycemia, and strengthen family confidence in home care.
Brazil and Cuba offered a useful contrast within the Region of the Americas. Brazil’s care was delivered at a secondary-level facility by a multidisciplinary team, with education for patients and families, specialist consultations, and community awareness initiatives. Cuba used a tertiary-level childhood diabetes clinic with similar educational priorities. Brazil also included internship programs for healthcare professionals and provided diabetes care free of charge, with extra resources for those in need. The clinical logic is straightforward: the more trained professionals a system can produce, the more likely it is to sustain specialized pediatric diabetes care over time.
Monitoring Systems and Databases Improved Clinical Follow-Up
Electronic or structured data systems featured in several models, especially where long-term follow-up and complication screening were part of routine care. In Morocco, a model that began in 1986 expanded from a single tertiary-level facility to nine provincial secondary-level hospitals and covered about one third of the country’s young patients with type 1 diabetes. Care included initial in-hospital treatment, then outpatient visits every three months. A database system supported electronic data monitoring, while self-management education was adapted for families with low literacy. Financial support came through sponsors and associations for low-income families, although insurance coverage remained limited to insulin costs.
Kazakhstan and Turkey in the European Region also emphasized monitoring. Kazakhstan provided free insulin, glucose meters, and test strips, along with a system for hypoglycemia and diabetic ketoacidosis monitoring. Turkey’s national program extended across multidisciplinary teams and school-based awareness efforts, yet financial barriers still affected access to some supplies and technologies. These models reinforce a basic principle of chronic disease care: regular data collection is not administrative overhead, it is the mechanism that allows clinicians to see whether treatment is failing before a child decompensates.
Complication Screening Remained Uneven Across Countries
The review also reveals wide variation in how systematically countries screened for complications. In the Western Pacific Region, Cambodia, Malaysia, Vietnam, and Laos were supported by Action4Diabetes, with free insulin, glucose meters, HbA1c testing, and emergency funds forming the backbone of care. Tertiary and secondary facilities delivered most of the care, although Vietnam relied on a single tertiary-level clinic. Multidisciplinary teams were present in Cambodia, Malaysia, and Vietnam, but not in Laos. Screening for diabetes complications was most comprehensive in Cambodia and Laos, while ongoing training for healthcare workers and electronic patient databases were integral to the program model.
This unevenness is clinically consequential. Children with type 1 diabetes need more than insulin replacement; they need surveillance for acute and chronic complications, and they need that surveillance to be predictable.
Sustainability Remains the Central Weakness
The review’s main conclusion is not that models of care are absent in low- and middle-income countries. It is that many of them depend on external partnerships, donor support, or program-specific funding streams that may not be durable enough to guarantee lifelong care. Across regions, the same strengths recur: free insulin, diabetes education, multidisciplinary teams, school and community programs, and monitoring systems. Across regions, the same gaps recur too: inconsistent access to supplies, fragmented financial protection, limited coverage of technologies, and variable screening for complications.
Those gaps have direct consequences for life expectancy and quality of life in children and adolescents. A child can be diagnosed and stabilized in one clinic, then lose access to strips, specialist review, or emergency care when the system weakens around them. The review does not provide outcomes in a single pooled estimate, but it does show where models are becoming more complete and where they still stop short of comprehensive chronic disease care. Future work will need to address whether these models can be sustained at national scale without relying so heavily on external support, and whether broader coverage can be achieved without leaving rural families and low-income households behind.